0002038768-24-000001.txt : 20240927 0002038768-24-000001.hdr.sgml : 20240927 20240927133259 ACCESSION NUMBER: 0002038768-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240927 DATE AS OF CHANGE: 20240927 EFFECTIVENESS DATE: 20240927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CTRL Therapeutics USA, Inc. CENTRAL INDEX KEY: 0001951690 ORGANIZATION NAME: IRS NUMBER: 883244754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-525226 FILM NUMBER: 241333308 BUSINESS ADDRESS: STREET 1: 655 SHERIDAN RD CITY: GLENCOE STATE: IL ZIP: 60022 BUSINESS PHONE: 415-640-8884 MAIL ADDRESS: STREET 1: 655 SHERIDAN RD CITY: GLENCOE STATE: IL ZIP: 60022 D 1 primary_doc.xml X0708 D LIVE 0001951690 CTRL Therapeutics USA, Inc. 655 SHERIDAN RD GLENCOE IL ILLINOIS 60022 415-640-8884 DELAWARE None None Corporation true 2022 Derrell Porter c/o CTRL Therapeutics USA, Inc. 655 Sheridan Rd. Glencoe IL ILLINOIS 60022 Executive Officer Director David O'Neill c/o CTRL Therapeutics USA, Inc. 655 Sheridan Rd. Glencoe IL ILLINOIS 60022 Director Collin Todd c/o CTRL Therapeutics USA, Inc. 655 Sheridan Rd. Glencoe IL ILLINOIS 60022 Director Shana Kelley c/o CTRL Therapeutics USA, Inc. 655 Sheridan Rd. Glencoe IL ILLINOIS 60022 Executive Officer Director Biotechnology Decline to Disclose 06b false 2024-09-19 false true false 0 9999998 9135991 864007 false 5 0 0 0 false CTRL Therapeutics USA, Inc. /s/ Derrell Porter Derrell Porter Chief Executive Officer 2024-09-26